1. 013 Effect of Intravaginal Prasterone on Sexual Dysfunction in Postmenopausal Women with Vulvovaginal Atrophy. (1st June 2016) Authors: Labrie, F.; DeRogatis, L.; Archer, D.F.; Martel, C. Journal: Journal of sexual medicine Issue: Volume 13(2016)Supplement 6 Page Start: S244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 015 Combined Data of Intravaginal Prasterone against Vulvovaginal Atrophy of Menopause. (1st June 2017) Authors: Labrie, F.; Archer, D.F.; Martel, C.; Vaillancourt, M.; Montesino, M. Journal: Journal of sexual medicine Issue: Volume 14(2017)Supplement 5 Page Start: e356 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy. Issue 3 (November 2015) Authors: Labrie, F.; Archer, D.F.; Portman, D. Journal: Maturitas Issue: Volume 82:Issue 3(2015:Nov.) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗